Panagiotis Garantziotis

662 total citations
26 papers, 402 citations indexed

About

Panagiotis Garantziotis is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, Panagiotis Garantziotis has authored 26 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 16 papers in Immunology and 7 papers in Oncology. Recurrent topics in Panagiotis Garantziotis's work include Systemic Lupus Erythematosus Research (16 papers), Atherosclerosis and Cardiovascular Diseases (9 papers) and T-cell and B-cell Immunology (5 papers). Panagiotis Garantziotis is often cited by papers focused on Systemic Lupus Erythematosus Research (16 papers), Atherosclerosis and Cardiovascular Diseases (9 papers) and T-cell and B-cell Immunology (5 papers). Panagiotis Garantziotis collaborates with scholars based in Greece, Germany and Sweden. Panagiotis Garantziotis's co-authors include George Βertsias, Philipp Enghard, Henrik E. Mei, Frederik Heinrich, Tobias Alexander, Mir‐Farzin Mashreghi, Gitta Anne Heinz, Robert Biesen, Falk Hiepe and Gerd R Burmester and has published in prestigious journals such as New England Journal of Medicine, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Panagiotis Garantziotis

22 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Panagiotis Garantziotis Greece 11 237 217 67 50 48 26 402
Gro Østli Eilertsen Norway 11 243 1.0× 247 1.1× 68 1.0× 25 0.5× 62 1.3× 22 367
GR Burmester Germany 10 310 1.3× 248 1.1× 66 1.0× 42 0.8× 54 1.1× 28 495
Maiko Yoshikawa Japan 11 340 1.4× 342 1.6× 69 1.0× 52 1.0× 68 1.4× 15 550
Imtiaz M Mumtaz Germany 6 229 1.0× 283 1.3× 61 0.9× 30 0.6× 35 0.7× 6 425
G Sturfelt Sweden 9 282 1.2× 246 1.1× 61 0.9× 54 1.1× 38 0.8× 10 434
Samy Metyas United States 6 289 1.2× 344 1.6× 150 2.2× 37 0.7× 31 0.6× 6 492
A M Delgado-Vega Sweden 12 278 1.2× 273 1.3× 64 1.0× 44 0.9× 60 1.3× 20 485
S N Wong China 8 218 0.9× 191 0.9× 53 0.8× 28 0.6× 32 0.7× 10 303
Iva Gunnarsson Sweden 7 281 1.2× 339 1.6× 70 1.0× 70 1.4× 134 2.8× 12 530
Emeli Lundström Sweden 8 367 1.5× 171 0.8× 148 2.2× 49 1.0× 34 0.7× 11 464

Countries citing papers authored by Panagiotis Garantziotis

Since Specialization
Citations

This map shows the geographic impact of Panagiotis Garantziotis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panagiotis Garantziotis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panagiotis Garantziotis more than expected).

Fields of papers citing papers by Panagiotis Garantziotis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panagiotis Garantziotis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panagiotis Garantziotis. The network helps show where Panagiotis Garantziotis may publish in the future.

Co-authorship network of co-authors of Panagiotis Garantziotis

This figure shows the co-authorship network connecting the top 25 collaborators of Panagiotis Garantziotis. A scholar is included among the top collaborators of Panagiotis Garantziotis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panagiotis Garantziotis. Panagiotis Garantziotis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garantziotis, Panagiotis, Dionysis Nikolopoulos, Anastasia Filia, et al.. (2025). Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosus. RMD Open. 11(1). e005050–e005050. 2 indexed citations
2.
Garantziotis, Panagiotis, Dionysis Nikolopoulos, Christina Adamichou, et al.. (2025). Systemic lupus erythematosus damage risk index (SLE-DRI): a simple machine learning-based tool for identifying patients at risk for early organ damage. RMD Open. 11(3). e006009–e006009. 1 indexed citations
3.
Garantziotis, Panagiotis, Janina Auth, G. Schett, & Christina Bergmann. (2025). CAR T-cell therapy in systemic sclerosis: the next frontier in immune modulation. Current Opinion in Rheumatology. 38(1). 60–68.
4.
Nikolopoulos, Dionysis, Panagiotis Garantziotis, Aggelos Banos, et al.. (2025). Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus. Annals of the Rheumatic Diseases. 84(8). 1342–1353. 1 indexed citations
5.
Garantziotis, Panagiotis, Julius Lindblom, Dionysis Nikolopoulos, et al.. (2025). DISTINCT MOLECULAR PROFILES OF REMISSION POST-CD19 CAR-T CELL THERAPY VERSUS STANDARD IMMUNOSUPPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS. The Journal of Rheumatology. 52(Suppl 1). 8–8.
6.
Taubmann, Jule, Sebastian Boeltz, Melanie Hagen, et al.. (2025). Langzeitverlauf von Effizienz und Sicherheit der CD19-CAR T-Zell-Therapie beim systemischen Lupus erythematodes. Zeitschrift für Rheumatologie. 84(8). 612–620. 1 indexed citations
7.
8.
Nikolopoulos, Dionysis, Panagiotis Garantziotis, Ioannis Parodis, et al.. (2024). Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events. Annals of the Rheumatic Diseases. 83(9). 1132–1143. 13 indexed citations
9.
Banos, Aggelos, Κonstantinos Thomas, Panagiotis Garantziotis, et al.. (2023). The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus. Frontiers in Immunology. 14. 1072598–1072598. 5 indexed citations
10.
Tsironis, C., et al.. (2023). Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction. Autoimmunity Reviews. 22(6). 103327–103327. 10 indexed citations
11.
Frangou, Eleni, Panagiotis Garantziotis, Aggelos Banos, et al.. (2022). Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis. Annals of the Rheumatic Diseases. 81(10). 1409–1419. 15 indexed citations
12.
Garantziotis, Panagiotis, Eleni Frangou, Anastasia Filia, et al.. (2022). Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs. Frontiers in Immunology. 13. 860726–860726. 19 indexed citations
13.
Nikolopoulos, Dionysis, Dimitrios K. Kitsos, Matilda Papathanasiou, et al.. (2022). Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the “Attikon” Lupus Cohort. Frontiers in Neurology. 13. 889613–889613. 16 indexed citations
14.
Ostendorf, Lennard, Panagiotis Garantziotis, Dimitrios L. Wagner, et al.. (2021). POS0010 CD38+ MEMORY T CELLS ARE A FUNCTIONALLY DISTINCT SUBSET THAT IS EXPANDED IN SLE AND ASSOCIATED WITH LUPUS NEPHRITIS. Annals of the Rheumatic Diseases. 80. 207–207.
15.
Nezos, Adrianos, Konstantinos Markakis, Panagiotis Garantziotis, et al.. (2021). Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?. Frontiers in Immunology. 12. 683623–683623. 11 indexed citations
16.
Gergianaki, Irini, et al.. (2021). High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete. Journal of Clinical Medicine. 10(5). 998–998. 36 indexed citations
17.
Nikolopoulos, Dionysis, Panagiotis Garantziotis, Dimitra Benaki, et al.. (2021). POS0421 COMBINED ANALYSIS OF METABOLIC AND TRANSCRIPTOMIC KIDNEY PROFILES OF NZW/B-F1 MURINE LUPUS UNCOVERS BIOLOGICAL MECHANISMS PRECEDING THE ONSET OF NEPHRITIS. Annals of the Rheumatic Diseases. 80. 439–440. 2 indexed citations
18.
Fragoulis, G., et al.. (2021). Unraveling the complexities of psoriatic arthritis by the use of -Omics and their relevance for clinical care. Autoimmunity Reviews. 20(11). 102949–102949. 6 indexed citations
19.
Nikolopoulos, Dionysis, Matilda Papathanasiou, Maria Chondrogianni, et al.. (2020). Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohort. Lara D. Veeken. 60(9). 4166–4174. 7 indexed citations
20.
Ostendorf, Lennard, Marie E. Burns, Pawel Durek, et al.. (2020). Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus. New England Journal of Medicine. 383(12). 1149–1155. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gro Østli Eilertsen Breakdown of academic impact, for papers by GR Burmester Breakdown of academic impact, for papers by Maiko Yoshikawa Breakdown of academic impact, for papers by Imtiaz M Mumtaz Breakdown of academic impact, for papers by G Sturfelt Breakdown of academic impact, for papers by Samy Metyas Breakdown of academic impact, for papers by A M Delgado-Vega Breakdown of academic impact, for papers by S N Wong Breakdown of academic impact, for papers by Iva Gunnarsson Breakdown of academic impact, for papers by Emeli Lundström
Rankless by CCL
2026